(Q47799201)

English

Systemic host responses in severe sepsis analyzed by causative microorganism and treatment effects of drotrecogin alfa (activated).

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/12830408

Systemic host responses in severe sepsis analyzed by causative microorganism and treatment effects of drotrecogin alfa (activated). (English)

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/12830408

1 reference

based on heuristic

inferred from title

drotrecogin alfa

1 reference

based on heuristic

inferred from title

Gordon R. Bernard

13

object named as

Gordon R Bernard

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/12830408

author name string

Steven M Opal

1

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/12830408

Gary E Garber

2

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/12830408

Steven P LaRosa

3

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/12830408

Dennis G Maki

4

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/12830408

Ross C Freebairn

5

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/12830408

Gary T Kinasewitz

6

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/12830408

Jean-Francois Dhainaut

7

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/12830408

S Betty Yan

8

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/12830408

Mark D Williams

9

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/12830408

Delores E Graham

10

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/12830408

David R Nelson

11

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/12830408

Howard Levy

12

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/12830408

language of work or name

0 references

publication date

24 June 2003

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/12830408

Clinical Infectious Diseases

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/12830408

37

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/12830408

1

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/12830408

50-58

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/12830408

Epidemiology of sepsis: an update

1 reference

https://api.crossref.org/works/10.1086%2F375593

21 January 2018

Clinical gram-positive sepsis: does it fundamentally differ from gram-negative bacterial sepsis?

1 reference

https://api.crossref.org/works/10.1086%2F375593

21 January 2018

Role of the coagulation system in the local and systemic inflammatory response.

1 reference

https://api.crossref.org/works/10.1086%2F375593

21 January 2018

Efficacy and safety of recombinant human activated protein C for severe sepsis

1 reference

https://api.crossref.org/works/10.1086%2F375593

21 January 2018

Clinical trials for severe sepsis. Past failures, and future hopes

1 reference

https://api.crossref.org/works/10.1086%2F375593

21 January 2018

Antibiotics in sepsis

1 reference

https://api.crossref.org/works/10.1086%2F375593

21 January 2018

A model of infected burn wounds using Escherichia coli O18:K1:H7 for the study of gram-negative bacteremia and sepsis

1 reference

https://api.crossref.org/works/10.1086%2F375593

21 January 2018

Activated protein C inhibits lipopolysaccharide-induced nuclear translocation of nuclear factor kappaB (NF-kappaB) and tumour necrosis factor alpha (TNF-alpha) production in the THP-1 monocytic cell line

1 reference

https://api.crossref.org/works/10.1086%2F375593

21 January 2018

Gene expression profile of antithrombotic protein c defines new mechanisms modulating inflammation and apoptosis

1 reference

https://api.crossref.org/works/10.1086%2F375593

21 January 2018

Protein C levels as a prognostic indicator of outcome in sepsis and related diseases

1 reference

https://api.crossref.org/works/10.1086%2F375593

21 January 2018

Review: infectious diseases and coagulation disorders

1 reference

https://api.crossref.org/works/10.1086%2F375593

21 January 2018

Prognostic value of protein C concentrations in neutropenic patients at high risk of severe septic complications

1 reference

https://api.crossref.org/works/10.1086%2F375593

21 January 2018

Identifiers

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/12830408

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/12830408

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47799201&oldid=1508846732"